Cargando…
A cross-sectional follow up study to estimate seroprevalence of coronavirus disease 2019 in Kobe, Japan
We conducted a study to estimate the seroprevalence of coronavirus disease 2019 (COVID-19) in Kobe, Japan with positive immunoglobulin G (IgG) rate of 3.3% (95% confidence interval [CI] 2.3%–4.6%) in April 2020. Because there were large concerns about the spread of COVID-19 among citizens thereafter...
Autores principales: | Doi, Asako, Iwata, Kentaro, Kuroda, Hirokazu, Hasuike, Toshikazu, Nasu, Seiko, Nishioka, Hiroaki, Tomii, Keisuke, Morimoto, Takeshi, Kihara, Yasuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191319/ https://www.ncbi.nlm.nih.gov/pubmed/35049228 http://dx.doi.org/10.1097/MD.0000000000028066 |
Ejemplares similares
-
Estimation of seroprevalence of novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: A cross-sectional study
por: Doi, Asako, et al.
Publicado: (2021) -
Clinical outcomes of COVID-19 caused by the Alpha variant compared with one by wild type in Kobe, Japan. A multi-center nested case-control study
por: Doi, Asako, et al.
Publicado: (2023) -
A pseudo-outbreak of COVID-19 associated pulmonary aspergillosis: a microbiological investigation of both the patients and the environment
por: Hasegawa, Kohei, et al.
Publicado: (2023) -
Interstitial nephritis caused by HIV infection by itself: a case report
por: Doi, Asako, et al.
Publicado: (2016) -
Patient-centered outcomes at hospital discharge in mechanically ventilated COVID-19 patients in Kobe, Japan: A single-center retrospective cohort study
por: Ito, Jiro, et al.
Publicado: (2022)